Na II - Search Results

1

High incidence of mucosa-associated lymphoid tissue in primary thyroid lymphoma: a clinicopathologic study of 18 cases in the Korean population.

Cho JH, Park YH, Kim WS, Oh SY, Cho SI, Kang HJ, Na II, Ryoo BY, Yang SH, Kim K, Jung CW, Park K, Ko YH, Lee SS. Cho JH, et al. Among authors: na ii. Leuk Lymphoma. 2006 Oct;47(10):2128-31. doi: 10.1080/10428190600783395. Leuk Lymphoma. 2006. PMID: 17071486

2

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.

Park YH, Kim WS, Kang HJ, Na II, Ryoo BY, Yang SH, Lee SS, Uhm JE, Kim K, Jung CW, Park K, Ko YH. Park YH, et al. Among authors: na ii. Ann Hematol. 2006 May;85(5):285-90. doi: 10.1007/s00277-005-0050-8. Epub 2006 Mar 4. Ann Hematol. 2006. PMID: 16518604

3

Primary gastric lymphoma of T-cell origin: clinicopathologic features and treatment outcome.

Park YH, Kim WS, Bang SM, Lee SI, Kang HJ, Na II, Yang SH, Lee SS, Uhm JE, Kwon JM, Kim K, Jung CW, Park K, Ko YH, Ryoo BY. Park YH, et al. Among authors: na ii. Leuk Res. 2006 Oct;30(10):1253-8. doi: 10.1016/j.leukres.2006.01.018. Epub 2006 Mar 9. Leuk Res. 2006. PMID: 16529813

4

Synchronous multiple primary lung cancers with different response to gefitinib.

Ryoo BY, Na II, Yang SH, Koh JS, Kim CH, Lee JC. Ryoo BY, et al. Among authors: na ii. Lung Cancer. 2006 Aug;53(2):245-8. doi: 10.1016/j.lungcan.2006.05.010. Epub 2006 Jun 19. Lung Cancer. 2006. PMID: 16787685

5

EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.

Na II, Kang HJ, Cho SY, Koh JS, Lee JK, Lee BC, Lee GH, Lee YS, Yoo HJ, Ryoo BY, Yang SH, Shim YS. Na II, et al. Eur J Cancer. 2007 Feb;43(3):520-6. doi: 10.1016/j.ejca.2006.09.025. Epub 2007 Jan 16. Eur J Cancer. 2007. PMID: 17224267

6

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.

Na II, Rho JK, Choi YJ, Kim CH, Park JH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. Lung Cancer. 2007 Jul;57(1):96-102. doi: 10.1016/j.lungcan.2007.01.027. Epub 2007 Mar 6. Lung Cancer. 2007. PMID: 17337084

7

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.

Na II, Rho JK, Choi YJ, Kim CH, Koh JS, Ryoo BY, Yang SH, Lee JC. Na II, et al. J Korean Med Sci. 2007 Jun;22(3):393-9. doi: 10.3346/jkms.2007.22.3.393. J Korean Med Sci. 2007. PMID: 17596643 Free PMC article.

8

Clinical significance of (18)F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: a retrospective study.

Na II, Cheon GJ, Choe DH, Byun BH, Kang HJ, Koh JS, Park JH, Baek H, Ryoo BY, Lee JC, Yang SH. Na II, et al. Lung Cancer. 2008 Apr;60(1):69-74. doi: 10.1016/j.lungcan.2007.09.010. Epub 2007 Oct 29. Lung Cancer. 2008. PMID: 18029051

9

18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer.

Na II, Byun BH, Kang HJ, Cheon GJ, Koh JS, Kim CH, Choe DH, Ryoo BY, Lee JC, Lim SM, Yang SH. Na II, et al. Clin Cancer Res. 2008 Apr 1;14(7):2036-41. doi: 10.1158/1078-0432.CCR-07-4074. Clin Cancer Res. 2008. PMID: 18381942

10

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.

Rho JK, Choi YJ, Lee JK, Ryoo BY, Na II, Yang SH, Kim CH, Lee JC. Rho JK, et al. Among authors: na ii. Lung Cancer. 2009 Feb;63(2):219-26. doi: 10.1016/j.lungcan.2008.05.017. Epub 2008 Jul 2. Lung Cancer. 2009. PMID: 18599154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters